Circular RNA Circ-0003006 Promotes Hepatocellular Carcinoma Proliferation and Metastasis Through Sponging miR-542-3p and Regulating HIF-1A
Qiang Tu,Xiaoxiang You,Jun He,Xuguang Hu,Changji Xie,Guohui Xu
DOI: https://doi.org/10.2147/CMAR.S315894
2021-10-13
Cancer Management and Research
Abstract:Qiang Tu, 1, 2 Xiaoxiang You, 1, 2 Jun He, 1, 2 Xuguang Hu, 1, 2 Changji Xie, 1, 2 Guohui Xu 1, 2 1 Department of Hepatobiliary Oncology Surgery, Jiangxi Cancer Hospital of Nanchang University, Nanchang, People's Republic of China; 2 Department of Oncology Interventional, Jiangxi Cancer Hospital of Nanchang University, Nanchang, People's Republic of China Correspondence: Qiang Tu Department of Hepatobiliary Oncology Surgery, Jiangxi Cancer Hospital of Nanchang University, No. 519, Beijing East Road, Nanchang, 330029, Jiangxi, People's Republic of China Email Introduction: Hepatocellular carcinoma (HCC) is one most common cancer types among gastrointestinal cancer over the world, while its underlying mechanisms remain unclear. CircRNA has been revealed to participate in multiple biological functions and contribute to various diseases' progression. Methods: Bioinformatic analysis of the differently expressed circRNAs in the HCC tissues, then verified by real-time quantitative PCR (RT-qPCR) assay. We found that circ-0003006 was upregulated in the HCC tissues, the cell fractionation assay and RNA fluorescence in situ hybridization (FISH) were performed to confirm the cell location of circ-0003006. shRNA silence assay was used to knock down the expression of circ-0003006 in the HCC cells. Results: Cell account kit 8 (CCK-8) and transwell assay were revealed that circ-0003006 knockdown inhibited the proliferation and metastasis in HCC cells. The target miR‐542‐3p and target gene HIF-1A were predicted by bioinformatics analysis, then verified through biotinylated RNA pull-down and dual-luciferase reporter assays. The mechanism, circ-0003006, probably acted as a sponge of miR‐542‐3p and regulated HIF-1A levels in hepatocellular carcinoma cells. Moreover, HIF-1A overexpression abolished the effect of circ-0003006 inhibition on the progression of hepatocellular carcinoma cells. The subcutaneous tumor formation experiment indicated that circ-0003006 knockdown inhibited the HCC cell growth in vivo. Conclusion: Circ-0003006 was demonstrated to promote HCC progression in vitro and in vivo by sponging miR‐542‐3p to release the inhibition on HIF-1A. Keywords: circular RNA, circ-0003006, miR-542-3p, HIF-1A, hepatocellular carcinoma Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and the second leading cause of tumor-related death. 1,2 In recent years, researchers have made significant progress in the treatment of hepatocellular carcinoma (HCC), including liver cancer resection, 3 liver transplantation, 3,4 radiofrequency ablation, 5 interventional therapy (chemotherapy and embolization), 6 and comprehensive treatment of targeted drugs. 7 Surgical resection is the best treatment of hepatocellular carcinoma (HCC), but because of hepatocellular carcinoma (HCC) onset conceals, early and no apparent symptoms. Most patients failed to do a related inspection, when liver area pain or particular symptoms, often lesions in the middle-late stage, thus intrahepatic and extrahepatic distant metastases, lost the optimal timing of surgery, leading to poor prognosis. 3 In addition, due to the atypical imaging of early micrometastatic lesions and the lack of biomarkers for screening early metastatic lesions, the patients with HCC still have a high recurrence rate after surgical resection, so the overall survival rate of HCC patients is still poor. 8 Therefore, it is of great significance for the patients with HCC to search for biomarkers related to early diagnosis, therapeutic intervention, and prognosis and to study the molecular mechanism of HCC occurrence and metastasis. CircRNA, as an essential part of non-coding RNAs, has received more and more attention in recent years due to their unique structure and potential functions. 9 In recent years, with the development of biological technology, especially bioinformatics and high-throughput sequencing technology, many circRNAs have been discovered. CircRNAs are a class of abundant, diverse, and highly conserved molecules with tissue-specific and developmental stage-specific expression levels. 10–12 As a large number of RNAs have been studied, our understanding of their functional mechanisms has deepened. Specifically, circRNAs may sponge on miRNAs, thereby blocking the translation of target gene mRNAs, influencing gene expression by regulating splicing sites, transcription, or interaction with RNA-binding proteins. 13–16 A large number of studies have shown that circRNAs play an essential role in biological processes. Som -Abstract Truncated-
oncology